Premium
E‐cigarette or vaping product use–associated lung injury: What is the role of cytologic assessment?
Author(s) -
Saqi Anjali,
Mukhopadhyay Sanjay,
Butt Yasmeen,
Doxtader Erika,
Heymann Jonas J.,
Larsen Brandon T.,
Moreira Andre L.,
Patel Ami,
Reynolds Jordan P.,
Sung Simon,
Crapanzano John P.
Publication year - 2020
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.22237
Subject(s) - medicine , bronchoalveolar lavage , lung , lung cancer , cytology , intensive care medicine , respiratory tract , cigarette smoking , pathology , respiratory system
Greater than 2000 cases of vaping‐associated pulmonary injury and 39 deaths reported in the United States have heightened public awareness and assumed major public health significance over recent months. Currently, knowledge of the effects of various vaping agents on the respiratory tract is in its infancy. Additional understanding of the agents implicated in these lung injuries as well as a correlation between bronchoalveolar lavage and lung biopsy samples is required.